New York Life Investment Management LLC Sells 564 Shares of Xylem Inc. (NYSE:XYL)

New York Life Investment Management LLC trimmed its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 1.5% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 37,453 shares of the industrial products company’s stock after selling 564 shares during the quarter. New York Life Investment Management LLC’s holdings in Xylem were worth $4,345,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Impax Asset Management Group plc boosted its stake in Xylem by 231.5% during the fourth quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company’s stock worth $644,039,000 after acquiring an additional 3,883,845 shares in the last quarter. Swedbank AB raised its holdings in shares of Xylem by 23.1% during the fourth quarter. Swedbank AB now owns 3,683,201 shares of the industrial products company’s stock valued at $427,325,000 after purchasing an additional 691,618 shares during the period. Erste Asset Management GmbH bought a new position in shares of Xylem during the 3rd quarter worth about $68,593,000. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Xylem in the 3rd quarter valued at about $52,169,000. Finally, Champlain Investment Partners LLC increased its position in Xylem by 17.8% in the 3rd quarter. Champlain Investment Partners LLC now owns 1,657,785 shares of the industrial products company’s stock valued at $223,851,000 after buying an additional 249,975 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Up 1.7 %

Xylem stock opened at $130.91 on Friday. Xylem Inc. has a fifty-two week low of $113.26 and a fifty-two week high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The firm’s 50-day simple moving average is $122.87 and its 200 day simple moving average is $127.20. The stock has a market cap of $31.80 billion, a PE ratio of 35.77, a price-to-earnings-growth ratio of 2.33 and a beta of 1.07.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.06. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.18 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.99 EPS. Research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th will be given a dividend of $0.40 per share. The ex-dividend date is Tuesday, February 18th. This is a positive change from Xylem’s previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a dividend yield of 1.22%. Xylem’s dividend payout ratio (DPR) is currently 43.72%.

Analyst Ratings Changes

Several brokerages have issued reports on XYL. TD Cowen cut their price target on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Citigroup cut Xylem from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 5th. Wolfe Research restated a “peer perform” rating on shares of Xylem in a research note on Thursday, December 12th. Stifel Nicolaus dropped their price objective on shares of Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a research note on Friday, January 24th. Finally, Robert W. Baird boosted their target price on shares of Xylem from $139.00 to $148.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and an average price target of $149.90.

Get Our Latest Research Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.